CARE Ratings Unveils Growth Strategy Amid Robust Q1 Performance Aug 05, 2025
More news about CARE Ratings
05Aug 25
CARE Ratings Posts 24% Profit Growth in Q1, Reappoints Two Independent Directors
CARE Ratings Limited reported a 24% year-on-year increase in consolidated net profit to ₹2,649.74 lakhs for Q1 FY2024. Consolidated revenue from operations grew 19% to ₹9,390.50 lakhs. The ratings segment revenue increased by 18%, while other segments saw 30% growth. The company reappointed two independent directors, Mr. G. Mahalingam and Mr. V. Chandrasekaran, for three-year terms. CARE Ratings also granted 7,500 stock options to employees and allotted 25,933 equity shares under its ESOS 2020.
05Aug 25
CARE Ratings Reports 24% Jump in Q1 Net Profit, Board Approves Director Reappointments
CARE Ratings Limited announced robust Q1 FY26 results, with consolidated net profit up 24% to ₹2,649.74 lakhs and revenue rising 19% to ₹9,390.50 lakhs. EPS improved to ₹8.61. The ratings business segment grew 18%, while non-ratings revenue increased by 30%. The company reappointed two Independent Directors and granted employee stock options. Management noted a positive start to FY26 despite global economic challenges.
02Jul 25
SAT Overturns Sebi's Two-Year Ban on Former Care Ratings MD
The Securities Appellate Tribunal (SAT) has quashed a two-year ban imposed by Sebi on Rajesh Mokashi, former Managing Director of CARE Ratings. SAT criticized Sebi's action as a 'misadventure' and ordered the regulator to pay ₹5 lakh to Mokashi for appeal costs. The ban was related to alleged credit rating manipulation. This ruling could potentially impact CARE Ratings' reputation positively and highlights the importance of checks and balances in India's financial regulatory system.
13May 25
CARE Ratings Posts Impressive Q4 Results: PAT Surges 29%, Stock Soars 15%
CARE Ratings, an Indian credit rating agency, reported a 29% year-over-year increase in Q4 PAT to Rs 44.90 crore. Q4 revenue grew by 22% to Rs 91.20 crore. EBITDA increased by 31% with a 50.00% margin. The company announced a final dividend of Rs 11.00 per share. For the full fiscal year 2025, PAT rose 24% to Rs 147.90 crore with a 19% revenue growth. The stock price surged 15% in response to these results.
12May 25
CARE Ratings: Q4 Profit Surges 76%, ₹11 Dividend Declared
CARE Ratings announced strong Q4 FY25 results with a 76.40% increase in net profit to ₹43.40 crore. Revenue grew by 21.90% to ₹109.70 crore, while EBITDA rose 64.80% to ₹47.70 crore with a 43.20% margin. The company declared a final dividend of ₹11.00 per share and reported its highest-ever annual income from operations for FY25.